AL
AVNS icon

Airain Ltd’s Avanos Medical AVNS Stock Holding History

Airain Ltd’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$399K Buy
+10,170
New +$384K 0.02% 595
2015
Q3 		– Sell
-5,241
Closed -$212K – 841
2015
Q2 		$212K Buy
+5,241
New +$235K 0.01% 737

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Airain Ltd's AVNS Position: Q2 2017 in Review

Airain Ltd opened a new position in Avanos Medical (AVNS) in Q2 2017: 10,170 shares worth $399K. The stake represents 0.02% of the portfolio and ranks #595 among its holdings. This is a return to the name: Airain Ltd previously reported a position in AVNS as recently as Q2 2015.

Airain Ltd first reported a position in AVNS in Q2 2015 and has held it in 2 quarters since. 328 funds tracked by Wall St. Rank hold AVNS as of Q2 2017.

  • Airain Ltd held 10,170 shares of Avanos Medical worth $399K as of Q2 2017.
  • Avanos Medical was a new Airain Ltd position in Q2 2017.
  • Avanos Medical made up 0.02% of Airain Ltd's portfolio in Q2 2017, its #595 holding.
  • Airain Ltd first reported a position in Avanos Medical in Q2 2015 and has held it in 2 quarters since.
  • 328 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.